Plus Total Assets from 2010 to 2024
PSTV Stock  USD 1.55 0.02 1.27% 
Total Assets  First Reported 20010331  Previous Quarter 11.4 M  Current Value 5.6 M  Quarterly Volatility 11.5 M 
Check Plus Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Plus Therapeutics' main balance sheet or income statement drivers, such as Interest Expense of 375.2 K, Selling General Administrative of 10.2 M or Selling And Marketing Expenses of 637 K, as well as many indicators such as Price To Sales Ratio of 1.06, Dividend Yield of 0.0022 or Days Sales Outstanding of 43.65. Plus financial statements analysis is a perfect complement when working with Plus Therapeutics Valuation or Volatility modules.
Plus  Total Assets 
Latest Plus Therapeutics' Total Assets Growth Pattern
Below is the plot of the Total Assets of Plus Therapeutics over the last few years. Total assets refers to the total amount of Plus Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Plus Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Plus Therapeutics' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Plus Therapeutics' overall financial position and show how it may be relating to other accounts over time.
View  Last Reported 11.39 M  10 Years Trend 

Total Assets 
Timeline 
Plus Total Assets Regression Statistics
Arithmetic Mean  27,192,307  
Geometric Mean  20,968,085  
Coefficient Of Variation  52.78  
Mean Deviation  11,885,180  
Median  23,991,000  
Standard Deviation  14,352,402  
Sample Variance  206T  
Range  50.5M  
RValue  (0.52)  
Mean Square Error  161.4T  
RSquared  0.27  
Significance  0.05  
Slope  (1,674,696)  
Total Sum of Squares  2883.9T 
Plus Total Assets History
Other Fundumenentals of Plus Therapeutics
Plus Therapeutics Total Assets component correlations
Click cells to compare fundamentals
About Plus Therapeutics Financial Statements
Plus Therapeutics investors use historical fundamental indicators, such as Plus Therapeutics' Total Assets, to determine how well the company is positioned to perform in the future. Understanding overtime patterns can help investors decide on longterm investments in Plus Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last Reported  Projected for Next Year  
Total Assets  11.4 M  10.8 M  
Intangibles To Total Assets  0.04  0.03 
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Plus Stock Analysis
When running Plus Therapeutics' price analysis, check to measure Plus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Plus Therapeutics is operating at the current time. Most of Plus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Plus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Plus Therapeutics' price. Additionally, you may evaluate how the addition of Plus Therapeutics to your portfolios can decrease your overall portfolio volatility.